CS1:PA:PA-Amundi IBEX 35 UCITS ETF Acc (EUR)

ETF | Others |

Last Closing

USD 318.6

Change

-9.75 (-2.97)%

Market Cap

USD 0.09B

Volume

1.23K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-1.01 (-2.15%)

USD 55.36B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

-20.10 (-3.55%)

USD 14.29B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

-13.90 (-3.44%)

USD 13.82B
WRD:PA HSBC MSCI World UCITS ETF

-1.18 (-3.25%)

USD 11.43B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-5.66 (-2.14%)

USD 9.11B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

-18.20 (-3.75%)

USD 8.85B
WLD:PA Lyxor UCITS MSCI World D-EUR

-12.14 (-3.36%)

USD 7.99B
HHH:PA HSBC S&P 500 UCITS ETF

-2.01 (-3.51%)

USD 7.71B
LCWD:PA Multi Units Luxembourg - Lyxor..

N/A

USD 6.91B
HSTE:PA HSBC ETFS PLC - HSBC Hang Seng..

-0.09 (-1.17%)

USD 5.25B

ETFs Containing CS1:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.46% 97% N/A 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.46% 97% N/A 85% B
Trailing 12 Months  
Capital Gain 34.01% 95% A 92% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 34.01% 95% A 91% A-
Trailing 5 Years  
Capital Gain 74.35% 73% C 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 74.35% 71% C- 75% C
Average Annual (5 Year Horizon)  
Capital Gain 15.83% 80% B- 78% C+
Dividend Return 15.83% 79% B- 77% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.95% 53% F 74% C
Risk Adjusted Return 122.27% 91% A- 97% N/A
Market Capitalization 0.09B 27% F 44% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.